Literature DB >> 212678

Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay.

R H Yolken, R G Wyatt, G Zissis, C D Brandt, W J Rodriguez, H W Kim, R H Parrott, J J Urrutia, L Mata, H B Greenberg, A Z Kapikian, R M Chanock.   

Abstract

To determine the relative importance of two known serotypes of human rotavirus, we developed an enzyme-linked immunosorbent assay to differentiate serotype-specific rotavirus antigen and antibody. Using this technic, we studied the epidemiology of the two serotypes in acute gastroenteritis. Seventy-seven per cent of 414 rotavirus isolates were Type 2, and the remainder were Type 1. The serotype distribution was similar in specimens from children in Washington, D.C., and other parts of the world. Sero-epidemiologic studies revealed that most children living in the Washington, D.C., area acquired antibody to both types by the age of two years. An analysis of children who were reinfected indicated that sequential infections usually involved different serotypes and that illness caused by one serotype did not provide resistance to illness caused by the other serotype. These results suggest that, to be completely effective, a vaccine must provide resistance to both serotypes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212678     DOI: 10.1056/NEJM197811232992103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  76 in total

1.  Great diversity of group A rotavirus strains and high prevalence of mixed rotavirus infections in India.

Authors:  V Jain; B K Das; M K Bhan; R I Glass; J R Gentsch
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Enzyme-linked fluorescence assay: Ultrasensitive solid-phase assay for detection of human rotavirus.

Authors:  R H Yolken; P J Stopa
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

3.  Ultrasensitive enzymatic radioimmunoassay: application to detection of cholera toxin and rotavirus.

Authors:  C C Harris; R H Yolken; H Krokan; I C Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

4.  Molecular epidemiology of rotaviruses associated with pediatric diarrhea in Bangkok, Thailand.

Authors:  P Pipittajan; S Kasempimolporn; N Ikegami; K Akatani; C Wasi; P Sinarachatanant
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

5.  Analysis of nonspecific reactions in enzyme-linked immunosorbent assay testing for human rotavirus.

Authors:  R H Yolken; P J Stopa
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

6.  Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988.

Authors:  G M Beards; U Desselberger; T H Flewett
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Rotavirus diarrhea severity is related to the VP4 type in Mexican children.

Authors:  Felipe Mota-Hernández; Juan José Calva; Claudia Gutiérrez-Camacho; Sofía Villa-Contreras; Carlos F Arias; Luis Padilla-Noriega; Héctor Guiscafré-Gallardo; María de Lourdes Guerrero; Susana López; Onofre Muñoz; Juan F Contreras; Roberto Cedillo; Ismael Herrera; Fernando I Puerto
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Rapid serotyping of human rotavirus strains by solid-phase immune electron microscopy.

Authors:  G Gerna; N Passarani; M Battaglía; E Percivalle
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  Molecular epidemiology of human rotaviruses. Analysis of outbreaks of acute gastroenteritis in Glasgow and the west of Scotland 1981/82 and 1982/83.

Authors:  E A Follett; R C Sanders; G M Beards; F Hundley; U Desselberger
Journal:  J Hyg (Lond)       Date:  1984-04

10.  Subgrouping of human rotavirus strains by complement fixation, indirect double-antibody sandwich enzyme-linked immunosorbent assay and solid-phase immune electron microscopy.

Authors:  G Gerna; M Torsellini; N Passarani; M Battaglia; E Percivalle; A Sarasini; D Torre; P Ferrante
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.